Clinical and Angiographic Outcomes With Sirolimus-Eluting Stents in Total Coronary Occlusions. The ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) Trial

JACC: Cardiovascular Interventions

Volumn 2, Issue 2, 2009, Pages 97-106

  Kandzari, David E ^a   Rao, Sunil V ^b   Moses, Jeffrey W ^c   Dzavik, Vladimir ^d   Strauss, Bradley H ^e   Kutryk, Michael J ^f   Simonton, Charles A ^g   Garg, Jyotsna ^b   Lokhnygina, Yuliya ^b   Mancini, G B John ^h   Yeoh, Eunice ^h   Buller, Christopher E ⁱ  

^a SCRIPPS CLINIC   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g CAROLINAS MEDICAL CENTER   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ Vancouver Health Department   (Canada)

Author keywords

drug eluting stent; fracture; sirolimus eluting stent; total coronary occlusion

Indexed keywords

RAPAMYCIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PRIORITY JOURNAL; RESTENOSIS; THROMBOSIS; TREATMENT FAILURE; AGED; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY RESTENOSIS; DRUG EFFECTS; HEALTH STATUS INDICATOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK; STATISTICAL MODEL; VASCULAR PATENCY;

AGED; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; SIROLIMUS; VASCULAR PATENCY;

EID: 59149105598     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.10.013     Document Type: Article

References (14)

1. Stone G.E., Kandzari D.E., Mehran R., et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 112 (2005) 2364-2372
2. Suttorp M.J., Laarman G.J., Rahel B.M., et al. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 114 (2006) 921-928
3. Ge L., Iakovou I., Cosgrave J., et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 26 (2005) 1056-1062
4. Hoye A., Tanabe K., Lemos P.A., et al. Significant reduction of restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol 43 (2004) 1954-1958
5. Nakamura S., Muthusamy T.S., Bae J.H., Cahyadi Y.H., Udayachalerm W., and Tresukosol D. Impact of the sirolimus-eluting stent on the outcome of patients with chronic total occlusions. Am J Cardiol 95 (2005) 161-166
6. Buellesfeld L., Gerckens U., Mueller R., Schmidt T., and Grube E. Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry. Catheter Cardiovasc Interv 66 (2005) 173-177
7. Kelbaek H., Helqvist S., Thuesen L., et al., SCANDSTENT Investigators. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) Trial. Am Heart J 152 (2006) 882-886
8. Buller C.E., Dzavik V., Carere R.G., et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation 100 (1999) 236-242
9. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
10. Lunceford J.K., and Davidian M. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med 23 (2004) 2937-2960
11. D'Agostino R.B. Propensity score methods for bias reduction in the comparison of treatment to a non-randomized control group. Stat Med 19 (1998) 2265-2281
12. Lin D.Y., Psaty B.M., and Kronmal R.A. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 54 (1998) 948-963
13. Werner G.S., Schwarz G., Prochnau D., et al. Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents. Catheter Cardiovasc Interv 67 (2006) 1-9
14. Aoki J., Nakazawa G., Tanabe K., et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 69 (2007) 380-386